IFNG and cancer: Furthermore, many studies have found that decreased magnitudes of T cell responses in cancer patients compared to healthy controls can be observed by quantification of interferon-γ (IFN-γ) using enzyme-linked immunospot (ELISPOT) assays or using flow-cytometry to detect T cell quantification assays or cytokine-producing T cells (34, 35).